| Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines C Kearon, EA Akl, AJ Comerota, P Prandoni, H Bounameaux, ... Chest 141 (2), e419S-e496S, 2012 | 4806 | 2012 |
| Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines SR Kahn, W Lim, AS Dunn, M Cushman, F Dentali, EA Akl, DJ Cook, ... Chest 141 (2), e195S-e226S, 2012 | 2014 | 2012 |
| Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review M Gianni, F Dentali, AM Grandi, G Sumner, R Hiralal, E Lonn European heart journal 27 (13), 1523-1529, 2006 | 1970 | 2006 |
| Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 A Bonaventura, A Vecchié, L Dagna, K Martinod, DL Dixon, ... Nature Reviews Immunology 21 (5), 319-329, 2021 | 849 | 2021 |
| Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura DM Arnold, F Dentali, MA Crowther, RM Meyer, RJ Cook, C Sigouin, ... Annals of internal medicine 146 (1), 25-33, 2007 | 779 | 2007 |
| European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis–endorsed by the European Academy of Neurology JM Ferro, MG Bousser, P Canhão, JM Coutinho, I Crassard, F Dentali, ... European stroke journal 2 (3), 195-221, 2017 | 748 | 2017 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients HJ Schünemann, M Cushman, AE Burnett, SR Kahn, J Beyer-Westendorf, ... Blood advances 2 (22), 3198-3225, 2018 | 742 | 2018 |
| Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients F Dentali, JD Douketis, M Gianni, W Lim, MA Crowther Annals of internal medicine 146 (4), 278-288, 2007 | 700 | 2007 |
| Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency W Lim, F Dentali, JW Eikelboom, MA Crowther Annals of internal medicine 144 (9), 673-684, 2006 | 594 | 2006 |
| Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature F Dentali, N Riva, M Crowther, AGG Turpie, GYH Lip, W Ageno Circulation 126 (20), 2381-2391, 2012 | 528 | 2012 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy DM Witt, R Nieuwlaat, NP Clark, J Ansell, A Holbrook, J Skov, N Shehab, ... Blood advances 2 (22), 3257-3291, 2018 | 514 | 2018 |
| American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients DR Anderson, GP Morgano, C Bennett, F Dentali, CW Francis, DA Garcia, ... Blood advances 3 (23), 3898-3944, 2019 | 450 | 2019 |
| Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists F Dentali, C Marchesi, MG Pierfranceschi, M Crowther, D Garcia, E Hylek, ... Thrombosis and haemostasis 106 (09), 429-438, 2011 | 380 | 2011 |
| Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis F Dentali, M Crowther, W Ageno Blood 107 (7), 2766-2773, 2006 | 359 | 2006 |
| Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation L Guasti, F Dentali, L Castiglioni, L Maroni, F Marino, A Squizzato, ... Thrombosis and haemostasis 106 (10), 591-599, 2011 | 316 | 2011 |
| Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial JM Ferro, JM Coutinho, F Dentali, A Kobayashi, A Alasheev, P Canhão, ... JAMA neurology 76 (12), 1457-1465, 2019 | 309 | 2019 |
| Natural history of cerebral vein thrombosis: a systematic review F Dentali, M Gianni, MA Crowther, W Ageno Blood 108 (4), 1129-1134, 2006 | 301 | 2006 |
| Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature F Dentali, AP Sironi, W Ageno, S Turato, C Bonfanti, F Frattini, S Crestani, ... Seminars in thrombosis and hemostasis 38 (05), 535-548, 2012 | 287 | 2012 |
| Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis F Dentali, W Ageno, C Becattini, L Galli, M Gianni, N Riva, D Imberti, ... Thrombosis research 125 (6), 518-522, 2010 | 283 | 2010 |
| Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding DM Witt, T Delate, DA Garcia, NP Clark, EM Hylek, W Ageno, F Dentali, ... Archives of internal medicine 172 (19), 1484-1491, 2012 | 279 | 2012 |
